Bain Capital Life Sciences Opportunities III, LP 13D and 13G filings for Disc Medicine, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 07:50 am Sale |
2024-12-31 | 13G | Disc Medicine, Inc. IRON |
Bain Capital Life Sciences Opportunities III, LP | 983,500 3.300% |
-812,235 (-45.23%) |
Filing |
| 2024-11-14 5:44 pm Purchase |
2024-09-30 | 13G | Disc Medicine, Inc. IRON |
Bain Capital Life Sciences Opportunities III, LP | 1,795,735 6.000% |
463,190 (+34.76%) |
Filing |
| 2024-02-13 6:51 pm Sale |
2023-12-31 | 13G | Disc Medicine, Inc. IRON |
Bain Capital Life Sciences Opportunities III, LP | 1,332,545 5.500% |
-658,369 (-33.07%) |
Filing |
| 2023-02-24 4:45 pm Purchase |
2023-02-15 | 13G | Disc Medicine, Inc. IRON |
Bain Capital Life Sciences Opportunities III, LP | 1,990,914 9.990% |
1,990,914 (New Position) |
Filing |